Close Menu

reagents

NEW YORK (GenomeWeb News) – eBioscience and Australian firm Anteo Diagnostics today announced a licensing deal covering Anteo's Mix&Go technology.

NEW YORK (GenomeWeb News) – Swedish firm Addtech Life Science today announced it has acquired BioNordika Holding.

NEW YORK (GenomeWeb News) – Sony DADC and Axela today announced they are partnering to develop and manufacture smart consumables for Axela's dotLab mX detection system.

Sony DADC and Maven Biotechnologies announced Wednesday a collaboration to develop and manufacture smart consumables for Maven's platform for performing cell-based assays and multiplexed biomarker detection.

NEW YORK (GenomeWeb News) – Corning on Thursday said it has completed its purchase of Mediatech for an undisclosed amount.

NEW YORK (GenomeWeb News) – AmberGen will provide its proprietary photocleavable biotin reagent for the commercial use with SomaLogic's Somascan technology platform under a deal announced on Tuesday.

NEW YORK (GenomeWeb News) – Affymetrix today announced a definitive agreement to buy eBioscience, a flow cytometry and immunoassay reagent firm, for $330 million in cash.

NEW YORK (GenomeWeb News) – Indian biotech firm Sisco Research Laboratories announced today the purchase of Madras Biotech for an undisclosed amount.

NEW YORK (GenomeWeb News) – Dyadic today announced it has raised $3 million through a private placement of convertible subordinated secured promissory notes to five undisclosed investors.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.